27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
- IMV Inc (NASDAQ:IMV) has priced its previously-announced underwritten public offering of 14.3 million shares at $1.75 per Unit, for gross proceeds of approximately $25 million.
- The offer price represents a discount of 16% from the last close price of $2.08 on Wednesday.
- Each Unit includes one common share and three-quarters of one common share purchase warrant.
- Each Warrant has an exercise price of $2.10 per share.
- The Company will use the proceeds to continue developing maveropepimut-S (DPX-Survivac) in various cancer indications and start developing a new product, DPX-SurMAGE, in bladder cancer.
- Wells Fargo Securities and Cantor are acting as joint book-running managers. BTIG is acting as lead manager, and iA Private Wealth is acting as co-manager.
- The offering will close by July 20.
- Price Action: IMV shares are down 22.1% at $1.62 during the premarket session on the last check Thursday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!